IN8BIO, INC. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
In8 Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • In8 Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.76M, a 42.3% increase year-over-year.
  • In8 Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $5.43M, a 34.3% increase year-over-year.
  • In8 Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.37M, a 26% increase from 2022.
  • In8 Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.47M, a 58% increase from 2021.
  • In8 Bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.2M, a 515% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.37M +$903K +26% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $3.47M +$1.27M +58% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $2.2M +$1.84M +515% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $357K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.